ArticleOncotarget2019

Crizotinib and PARP inhibitors act synergistically by triggering apoptosis in high-grade serous ovarian cancer.

Irem Durmaz Sahin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.